Skip to main content

Table 3 PR of screening non-participation by the selected CDGs ≤2 years and >2–10 years before screening (n = 144,264)

From: Non-participation in breast cancer screening for women with chronic diseases and multimorbidity: a population-based cohort study

  Unadjusted Model 1a Model 2b
  ≤2 years >2–10 years ≤2 years >2–10 years ≤2 years >2–10 years
  PR (95 % CI) PR (95 % CI) PR (95 % CI) PR (95 % CI) PR (95 % CI) PR (95 % CI)
Cardiovascular diseases      
 No 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref)
 Yes 1.24 (1.16–1.31) 1.16 (1.11–1.21) 1.13 (1.06–1.21) 1.04 (0.99–1.09) 1.05 (0.99–1.13) 0.98 (0.93–1.02)
Cancer      
 No 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref)
 Yes 1.63 (1.54–1.74) 1.19 (1.11–1.27) 1.56 (1.46–1.66) 1.16 (1.08–1.24) 1.50 (1.40–1.60) 1.10 (1.03–1.17)
Hypertension      
 No 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref)
 Yes 1.00 (0.91–1.09) 0.99 (0.93–1.06) 0.97 (0.87–1.07) 0.97 (0.91–1.04) 0.92 (0.83–1.02) 0.93 (0.87–0.99)
Chronic mental illness      
 No 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref)
 Yes 1.93 (1.82–2.04) 1.78 (1.71–1.86) 1.62 (1.53–1.71) 1.51 (1.44–1.57) 1.51 (1.42–1.60) 1.40 (1.35–1.46)
Diabetes      
 No 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref)
 Yes 1.27 (1.19–1.36) 1.41 (1.33–1.50) 1.14 (1.06–1.22) 1.23 (1.17–1.31) 1.05 (0.97–1.13) 1.10 (1.04–1.17)
Chronic obstructive pulmonary disease     
 No 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref)
 Yes 1.87 (1.75–1.99) 1.68 (1.59–1.78) 1.62 (1.52–1.73) 1.43 (1.35–1.52) 1.51 (1.42–1.62) 1.32 (1.24–1.40)
Chronic neurological disorders     
 No 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref)
 Yes 1.50 (1.35–1.65) 1.57 (1.44–1.71) 1.36 (1.23–1.50) 1.40 (1.29–1.52) 1.24 (1.12–1.37) 1.23 (1.13–1.34)
Chronic arthritis       
 No 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref)
 Yes 1.02 (0.90–1.15) 1.04 (0.94–1.16) 0.97 (0.86–1.10) 0.99 (0.89–1.11) 0.90 (0.80–1.02) 0.89 (0.80–1.00)
Chronic bowel disease     
 No 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref)
 Yes 0.80 (0.68–0.94) 0.79 (0.69–0.90) 0.81 (0.69–0.94) 0.78 (0.68–0.89) 0.75 (0.65–0.88) 0.71 (0.61–0.81)
Chronic liver disease      
 No 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref)
 Yes 1.40 (1.17–1.67) 1.47 (1.26–1.72) 1.20 (1.00–1.43) 1.24 (1.06–1.43) 1.12 (0.93–1.34) 1.08 (0.92–1.26)
Chronic kidney disease     
 No 1 (ref) (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref)
 Yes 2.22 (1.94–2.55) 1.83 (1.57–2.14) 1.93 (1.69–2.20) 1.61 (1.36–1.90) 1.70 (1.49–1.94) 1.40 (1.19–1.65)
  1. aAdjusted for age, ethnicity, marital status and education
  2. bAdjusted for age, ethnicity, marital status, education, for being registered in the NPR or PCRR with the other studied chronic diseases, and for being registered in the NPR or PCRR with one of the CDGs in the other time period (yes/no). E.g. cancer 0–2 year before screening is adjusted for SEP, for the remaining 10 studied diseases and for being in hospital contact with one of the 11 included chronic disease groups >2–10 years before screening
  3. Statistically significant results in bold